As Stan Au’s Parkinson’s disease symptoms progressed, everyday activities became daily battles. His hands shook so badly that he struggled to hold utensils and couldn’t sign his name. He stopped playing pickleball—a sport he once enjoyed—despite taking a widely prescribed medication for managing motor symptoms, such as rigidity or stiffness, slow movement, involuntary muscle movement (dyskinesia) and tremors.

An updated Cochrane review has found that ergonomic interventions show no meaningful benefit for pain, function, recovery or sick leave in workers with work-related complaints of the arm, neck or shoulder (CANS), compared with no treatment.

A new alpha-emitting radiopharmaceutical therapy (RPT) for advanced prostate cancer was well tolerated, with no dose-limiting toxicities observed, and showed encouraging signs of antitumor activity, according to a trial published in The Journal of Nuclear Medicine’s Late-Breaking Fast Track.

New research by the Medicines and Healthcare products Regulatory Agency (MHRA) in partnership with the GSK Vaccines Institute for Global Health has moved a vaccine against the highly contagious group A streptococcus bacterium (Strep A) a step closer to reality.

Reliably recording brain activity over many hours has so far been fraught with technical and practical challenges. While traditional electroencephalography (EEG) systems provide meaningful data, they are often uncomfortable and typically limited to controlled testing environments. Is it even possible to record EEG signals with good signal quality in everyday situations?